The FDA, while promising flexibility in approving Baby KJ-type gene editing, still has set standards difficult for a small ...

Jennifer Doudna was staring at a computer screen filled with a string of As, Cs, Ts, and Gs—the letters that make up human DNA—and witnessing a debilitating genetic disease being cured right before ...

Biotech raises $128.7 million to continue its work on genetic medicines to reduce cardiovascular disease.

CRISPR co-creator Jennifer Doudna on watching her groundbreaking gene-editing technology help sickle cell patients: “It’s extraordinary.” Jennifer Doudna codeveloped the revolutionary gene-editing ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The second cohort is going ...

Jennifer Doudna, a UC Berkeley biochemist who shared the 2020 Nobel Prize in Chemistry for the invention of CRISPR-Cas9 genome editing, has been awarded a National Medal of Technology and Innovation, ...

Biochemist Jennifer Doudna received the inaugural Kimberly Prize in Biochemistry and Molecular Genetics at the Robert H. Lurie Medical Research Center on Tuesday. The prize will be awarded annually to ...

Nobel Prize winner and CRISPR DNA-editing pioneer Jennifer A. Doudna, PhD, spoke Thursday at Fred Hutch Cancer Center in Seattle. Her lecture kicked off the President’s Seminar series, presented by ...

The award to Dr. Jennifer Doudna was presented on March 24, at a special ceremony in France. Dr. Doudna is a professor in the department of molecular and cell biology at the University of California, ...

Jennifer Doudna, one of the pioneers of the gene-editing technique known as CRISPR, thinks the biotech tool could be an essential one for combating COVID-19 and future pandemics. Due to its capacity ...

The Department of Energy announced the development of a new supercomputer at the National Energy Research Scientific Computing Center, or NERSC, a facility at Lawrence Berkeley National Laboratory, or ...